Unique trends are occurring in the pharmaceutical pipeline that would have been unheard of just five years ago.
Preparing for pharmacy policy changes can help your managed care organization stay ahead of the competition. Here, pharmacy experts highlight three areas to watch closely.
Some of the most amazing things are happening in the delivery of medical care these days. Surgical techniques, new devices, drugs, and diagnostics can treat and cure many medical conditions.
Legislation removes FDA involvement when patients seek experimental medications. Here’s what critics and proponents say.
There are roughly 100 autoimmune diseases, plus about 40 more that are immune-based.
The International Rare Diseases Research Consortium hopes to develop 200 new drugs for rare diseases by 2020, and it seems as if things are better than on track.
The cost to treat cancer in the United States could reach $156 billion in 2020, according to the National Cancer Institute. And innovative medications have a significant impact on the cost of care.
Payers are stepping up efforts to manage the cost and utilization of orphan drug treatments.
To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2018.
This first article in our new leadership series explores how managed care executives can cultivate smart ideas and stay ahead of the competition.